Latest News
SeaStar Medical Holding Corporation
- SeaStar Medical reports survival data for pediatric AKI device
- SeaStar Medical Reports Statistically Significant Survival
- SeaStar Medical CMO receives combat nephrology award
- SeaStar Medical Receives FDA Breakthrough Device Designation for SCD Therapy in Adult Sepsis and Septic Conditions
- FDA grants SeaStar Medical breakthrough device status for sepsis therapy
- SeaStar Medical raises $3.3M via warrant exercise offering
- SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds
- SeaStar Medical’s deal would give investors rights to buy up to 1.71 million shares.
- SeaStar Medical raises $3.3M through warrant exercise By Investing.com
- SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026
- SeaStar Medical’s SAVE Registry Data Accepted for Late-Breaking Poster Presentation at ASN Kidney Week 2026
- SeaStar Medical Announces New ICD-10-PCS Codes for QUELIMMUNE and Selective Cytopheresis Therapy in Acute Kidney Injury
Headlines from the last 30 days, linking to the original publishers. See all market news →